fda semaglutide warning november 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and Tirzepatide "kits" Semaglutide: Shedding pounds, weighing risks

Using the cryo-EM density map we built and refined a near atomic resolution structure of the GLP-1:GLP-1R:Gs complex

While she could tolerate the 0.25 mg initiation dose, even that level increased her risk of hypoglycemia

[DOI] [PMC free article] [PubMed] [Google Scholar] 217

Steady-State Exposure Evaluation for Subcutaneous Semaglutide A one-compartment model, similar to the one used to evaluate phase 3 data, was investigated using steady-state data from subcutaneous dosing only in clinical pharmacology trials

Alkem said the new launch reflects its focus on expanding access to high-quality and affordable medicines across key therapeutic areas while supporting better patient care in India